These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 9760479)
1. Harmonization of genotoxicity testing requirements for pharmaceuticals. Sofuni T J Toxicol Sci; 1998 Jul; 23 Suppl 2():262-4. PubMed ID: 9760479 [No Abstract] [Full Text] [Related]
2. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes. Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131 [TBL] [Abstract][Full Text] [Related]
3. The in vivo comet assay: use and status in genotoxicity testing. Brendler-Schwaab S; Hartmann A; Pfuhler S; Speit G Mutagenesis; 2005 Jul; 20(4):245-54. PubMed ID: 15899933 [TBL] [Abstract][Full Text] [Related]
4. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH). Kamath GH; Rao KS Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892 [TBL] [Abstract][Full Text] [Related]
5. Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment. Blakey D; Galloway SM; Kirkland DJ; MacGregor JT Mutat Res; 2008 Nov; 657(1):84-90. PubMed ID: 18926925 [TBL] [Abstract][Full Text] [Related]
6. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice. Food and Drug Administration, HHS Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039 [TBL] [Abstract][Full Text] [Related]
7. Appropriate levels of cytotoxicity for genotoxicity tests using mammalian cells in vitro. Müller L; Sofuni T Environ Mol Mutagen; 2000; 35(3):202-5. PubMed ID: 10737955 [TBL] [Abstract][Full Text] [Related]
8. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity. Snyder RD Environ Mol Mutagen; 2009 Jul; 50(6):435-50. PubMed ID: 19334052 [TBL] [Abstract][Full Text] [Related]
9. Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Brambilla G; Mattioli F; Martelli A Toxicology; 2009 Jul; 261(3):77-88. PubMed ID: 19410629 [TBL] [Abstract][Full Text] [Related]
10. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme. Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363 [TBL] [Abstract][Full Text] [Related]
11. Strategy for genotoxicity testing--metabolic considerations. Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S; Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Kirkland D; Aardema M; Müller L; Makoto H Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241 [TBL] [Abstract][Full Text] [Related]
13. Genotoxicity and carcinogenicity studies of antihypertensive agents. Brambilla G; Martelli A Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045 [TBL] [Abstract][Full Text] [Related]
14. Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol. Maralhas A; Monteiro A; Martins C; Kranendonk M; Laires A; Rueff J; Rodrigues AS Mutagenesis; 2006 May; 21(3):199-204. PubMed ID: 16595588 [TBL] [Abstract][Full Text] [Related]
15. Characterization and mechanisms of chromosomal alterations induced by benzene in mice and humans. Eastmond DA; Schuler M; Frantz C; Chen H; Parks R; Wang L; Hasegawa L Res Rep Health Eff Inst; 2001 Jun; (103):1-68; discussion 69-80. PubMed ID: 11504146 [TBL] [Abstract][Full Text] [Related]
16. Cytogenetic evaluation for genotoxicity of bisphenol-A in bone marrow cells of Swiss albino mice. Naik P; Vijayalaxmi KK Mutat Res; 2009 May; 676(1-2):106-12. PubMed ID: 19393337 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Kirkland D; Aardema M; Henderson L; Müller L Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392 [TBL] [Abstract][Full Text] [Related]
18. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes. Cimino MC Environ Mol Mutagen; 2006 Jun; 47(5):362-90. PubMed ID: 16649190 [TBL] [Abstract][Full Text] [Related]
19. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E; Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. Thresiamma KC; George J; Kuttan R J Exp Clin Cancer Res; 1998 Dec; 17(4):431-4. PubMed ID: 10089063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]